These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35734982)

  • 1. Multigene Panel Testing in Turkish Hereditary Cancer Syndrome Patients.
    Arslan Ates E; Turkyilmaz A; Alavanda C; Yildirim O; Guney AI
    Medeni Med J; 2022 Jun; 37(2):150-158. PubMed ID: 35734982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DSM-5 TÜRKÇE ÇEVİRİYE BİR KISMİ ELEŞTİRİ.
    Özdemir O
    Turk Psikiyatri Derg; 2022; 33(3):220-222. PubMed ID: 36148574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of
    Yıldız İ; Ertuğ S; Tileklioğlu E; Malatyalı E; Güçlü Ö; Ertabaklar H
    Turkiye Parazitol Derg; 2021 Aug; 45(3):195-200. PubMed ID: 34346875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the relationship between Hemoglobin, Albumin, Lymphocyte, Platelet (HALP) score and treatment modality and mortality in patients with ileus.
    Bildik B; Çekmen B; Atiş ŞE; Günaydın YK; Dorter M
    Ulus Travma Acil Cerrahi Derg; 2023 Dec; 29(12):1351-1356. PubMed ID: 38073459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Parasitic Diseases in Patients Brought to Fırat University Animal Hospital.
    Gündoğ SÖ; Çelik F; Şimşek S
    Turkiye Parazitol Derg; 2021 Dec; 45(4):268-273. PubMed ID: 34889194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive Onset Multiple Sclerosis: Demographic, Clinical and Laboratory Characteristics of Patients With and Without Relapses in the Course.
    Kaymakamzade B; Kiliç AK; Kurne AT; Karabudak R
    Noro Psikiyatr Ars; 2019 Mar; 56(1):23-26. PubMed ID: 30911233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uncommon variants detected via hereditary cancer panel and suggestions for genetic counseling.
    Özdemir Z; Çevik E; Öksüzoğlu ÖBÇ; Doğan M; Ateş Ö; Esin E; Bilgetekin İ; Demirci U; Köseoğlu Ç; Topal A; Karadurmuş N; Erdem HB; Bahsi T
    Mutat Res; 2023; 827():111831. PubMed ID: 37453313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Importance of Antioxidant Enzymes and Oxidative Stress in Human Fascioliasis.
    Taş Cengiz Z; Yılmaz H; Beyhan YE; Ekici A; Çiçek M; Aydemir S
    Turkiye Parazitol Derg; 2023 Mar; 47(1):38-41. PubMed ID: 36872484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast and Ovarian Cancer Penetrance Estimates Derived From Germline Multiple-Gene Sequencing Results in Women.
    Kurian AW; Hughes E; Handorf EA; Gutin A; Allen B; Hartman AR; Hall MJ
    JCO Precis Oncol; 2017 Nov; 1():1-12. PubMed ID: 35172496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of Germline Non-BRCA Mutation Status of High-Risk Breast Cancer Patients in China and Correlation with High-Risk Factors and Multigene Testing Suggestions.
    Su Y; Yao Q; Xu Y; Yu C; Zhang J; Wang Q; Li J; Shi D; Yu B; Zeng Y; Zhu X; Bai Q; Zhou X
    Front Genet; 2021; 12():674094. PubMed ID: 34917121
    [No Abstract]   [Full Text] [Related]  

  • 11. [The French Genetic and Cancer Consortium guidelines for multigene panel analysis in hereditary breast and ovarian cancer predisposition].
    Moretta J; Berthet P; Bonadona V; Caron O; Cohen-Haguenauer O; Colas C; Corsini C; Cusin V; De Pauw A; Delnatte C; Dussart S; Jamain C; Longy M; Luporsi E; Maugard C; Nguyen TD; Pujol P; Vaur D; Andrieu N; Lasset C; Noguès C;
    Bull Cancer; 2018 Oct; 105(10):907-917. PubMed ID: 30268633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of germline pathogenic variants in DNA damage repair genes by a next-generation sequencing multigene panel in BRCAX patients.
    Rodríguez-Balada M; Roig B; Melé M; Albacar C; Serrano S; Salvat M; Querol M; Borràs J; Martorell L; Gumà J
    Clin Biochem; 2020 Feb; 76():17-23. PubMed ID: 31786208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologic findings in breast, fallopian tube, and ovary specimens in non-BRCA hereditary breast and/or ovarian cancer syndromes: a study of 18 patients with deleterious germline mutations in RAD51C, BARD1, BRIP1, PALB2, MUTYH, or CHEK2.
    Schoolmeester JK; Moyer AM; Goodenberger ML; Keeney GL; Carter JM; Bakkum-Gamez JN
    Hum Pathol; 2017 Dec; 70():14-26. PubMed ID: 28709830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exon splicing analysis of intronic variants in multigene cancer panel testing for hereditary breast/ovarian cancer.
    Ryu JS; Lee HY; Cho EH; Yoon KA; Kim MK; Joo J; Lee ES; Kang HS; Lee S; Lee DO; Lim MC; Kong SY
    Cancer Sci; 2020 Oct; 111(10):3912-3925. PubMed ID: 32761968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New germline mutations in BRCA1, ATM, MUTYH, and RAD51D genes in Tuvans early-onset breast cancer patients.
    Gervas P; Molokov A; Ivanova A; Panferova Y; Kiselev A; Chernyshova A; Pisareva L; Choynzonov E; Cherdyntseva N
    Exp Oncol; 2021 Mar; 43(1):52-55. PubMed ID: 33785725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer.
    Pearlman R; Frankel WL; Swanson B; Zhao W; Yilmaz A; Miller K; Bacher J; Bigley C; Nelsen L; Goodfellow PJ; Goldberg RM; Paskett E; Shields PG; Freudenheim JL; Stanich PP; Lattimer I; Arnold M; Liyanarachchi S; Kalady M; Heald B; Greenwood C; Paquette I; Prues M; Draper DJ; Lindeman C; Kuebler JP; Reynolds K; Brell JM; Shaper AA; Mahesh S; Buie N; Weeman K; Shine K; Haut M; Edwards J; Bastola S; Wickham K; Khanduja KS; Zacks R; Pritchard CC; Shirts BH; Jacobson A; Allen B; de la Chapelle A; Hampel H;
    JAMA Oncol; 2017 Apr; 3(4):464-471. PubMed ID: 27978560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel genetic mutations detected by multigene panel are associated with hereditary colorectal cancer predisposition.
    Martin-Morales L; Rofes P; Diaz-Rubio E; Llovet P; Lorca V; Bando I; Perez-Segura P; de la Hoya M; Garre P; Garcia-Barberan V; Caldes T
    PLoS One; 2018; 13(9):e0203885. PubMed ID: 30256826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline pathogenic variant spectrum in 25 cancer susceptibility genes in Turkish breast and colorectal cancer patients and elderly controls.
    Akcay IM; Celik E; Agaoglu NB; Alkurt G; Kizilboga Akgun T; Yildiz J; Enc F; Kir G; Canbek S; Kilic A; Zemheri E; Ezberci F; Ozcelik M; Dinler Doganay G; Doganay L
    Int J Cancer; 2021 Jan; 148(2):285-295. PubMed ID: 32658311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial and ethnic variation in multigene panel testing in a cohort of BRCA1/2-negative individuals who had genetic testing in a large urban comprehensive cancer center.
    Tatineni S; Tarockoff M; Abdallah N; Purrington KS; Assad H; Reagle R; Petrucelli N; Simon MS
    Cancer Med; 2022 Mar; 11(6):1465-1473. PubMed ID: 35040284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Contribution of Next-Generation Sequencing Multigene Panel Testing for BRCA Negative High-Risk Patients With Breast Cancer.
    Ece Solmaz A; Yeniay L; Gökmen E; Zekioğlu O; Haydaroğlu A; Bilgen I; Özkınay F; Onay H
    Clin Breast Cancer; 2021 Dec; 21(6):e647-e653. PubMed ID: 33980423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.